TB Treatment Success Rate in Ethiopia: Key Findings & Challenges

Tuberculosis (TB) remains a major global health issue, infecting one-third of the world's population. Despite efforts, Ethiopia's TB treatment success rate remains below the WHO End TB target (≥90%).

A systematic review and meta-analysis examined drug-susceptible TB treatment outcomes from 2015 to 2023, analyzing 43 observational studies covering 35,046 patients.

Key Findings: TB Treatment Success Rate in Ethiopia 

➡️ Related: Treatment Outcomes and Interrelated Factors amongPatients with Drug-Susceptible Tuberculosis in Ethiopiafrom Espousal of “New Post-2015 End TB Strategy” toEnd of 2023: A Systematic Review and Meta-Analysis

Overall Success Rate: 82.4% (95% CI: 79.04% – 85.7%)
Regional Disparities:

• Sidama (95.5%), Addis Ababa (90.5%), Harari (89.9%)
• Afar (84.2%), Amhara (82.5%), Oromia (80.2%)
• Southwest Ethiopia (55.4%) – Lowest rate
  

Key Risk Factors for Poor Outcomes:

• Pulmonary TB (Smear -/+)
• Older age & rural residence
• TB/HIV co-infection & HIV-positive status
• Retreatment cases
• Distance from healthcare facilities

Conclusion: Need for Targeted Interventions. Ethiopia's TB treatment success rate is below the WHO End TB strategy threshold. To improve outcomes, special attention is needed for:

• Regions with lower success rates
• TB/HIV co-infected & retreatment cases
• Older patients & rural communities

Corresponding author: Moges Getie Workie**

Full Length Article: Treatment Outcomes and Interrelated Factors amongPatients with Drug-Susceptible Tuberculosis in Ethiopiafrom Espousal of “New Post-2015 End TB Strategy” toEnd of 2023: A Systematic Review and Meta-Analysis

Journal: Austin Tuberculosis: Research & Treatment

Disclaimer: This content is not owned or created by us. It has been sourced from the respective site, Austin Publishing Group, and is intended purely for study and educational purposes. All rights belong to the original authors and publishers.